ClinicalTrials.gg
Drug

Tebipenem clinical trials

Also written SPR994 and TBPM-PI-HBr.

studies test it
13
open now
0
in phase 3
2
first study started
2017

How each study uses tebipenem is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
17 Jun 2026 · UTEBZI · NDA 215960 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

TBP-PI-HBr
3
Tebipenem pivoxil hydrobromide (TBPM-PI-HBr)
3
TBPM-PI-HBr oral capsule
2

Development codes

SPR994
9
TBPM-PI-HBr
6

Studies by the year they started

13 studies that test it; most in 2020 (6)

Studies that test tebipenem, by start year
YearStudies
20171
20192
20206
20211
20232
20241

By phase

A phase 1/2 study counts in both.

Phase 1
11
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 12 · Other 1

Spero Therapeutics (12) · Hartford Hospital (1)

Studies

Open first, then newest update. How each study uses tebipenem is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13

Codes

What other systems call tebipenem · ClinicalTrials.gg INT004773

  • MeSH (NLM) C500135tebipenemOne source NLM
  • UNII (FDA) Q2TWQ1I31UTEBIPENEMConfirmed FDA, NLM, Wikidata
  • Wikidata Q27286930tebipenemConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C219319TebipenemOne source FDA

Also registered as tebipenem pivoxil hydrobromide (UNII NT65DX774J).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.